Proto-Oncogene Proteins B-raf, antagonists & inhibitors
- Name
- Proto-Oncogene Proteins B-raf, antagonists & inhibitors
- Accession Number
- DBCAT001918
- Description
Not Available
- Drugs
Drug Drug Description Dabrafenib A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. Agerafenib Agerafenib is under investigation in clinical trial NCT03052569 (Expanded Access to RXDX-105 for Cancers With RET Alterations). - Drugs & Drug Targets